A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Clinical trial NCT06224348 · COMPLETED

Trial details

NCT number: NCT06224348
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatitis Atopic

Start date: 2024-01-18
Primary completion: 2025-08-21
Enrollment: 643

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.